Reviews - 1iyt mentioned but not cited (14)
- Amyloid beta: structure, biology and structure-based therapeutic development. Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, Xu HE. Acta Pharmacol Sin 38 1205-1235 (2017)
- The amyloid-beta precursor protein: integrating structure with biological function. Reinhard C, Hébert SS, Hébert SS, De Strooper B. EMBO J 24 3996-4006 (2005)
- Alzheimer's disease: which type of amyloid-preventing drug agents to employ? Jang H, Connelly L, Arce FT, Ramachandran S, Lal R, Kagan BL, Nussinov R. Phys Chem Chem Phys 15 8868-8877 (2013)
- Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases. Gonçalves PB, Sodero ACR, Cordeiro Y. Biomolecules 11 767 (2021)
- Mamma Mia, P-glycoprotein binds again. Callaghan R, Gelissen IC, George AM, Hartz AMS. FEBS Lett 594 4076-4084 (2020)
- Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease. Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkowski JM. Neuropsychiatr Dis Treat 17 1311-1339 (2021)
- Aducanumab-Hope or Disappointment for Alzheimer's Disease. Wojtunik-Kulesza K, Rudkowska M, Orzeł-Sajdłowska A. Int J Mol Sci 24 4367 (2023)
- Alzheimer's disease--a panorama glimpse. Zhao LN, Lu L, Chew LY, Mu Y. Int J Mol Sci 15 12631-12650 (2014)
- Structural biology of cell surface receptors implicated in Alzheimer's disease. Hermans SJ, Nero TL, Morton CJ, Gooi JH, Crespi GAN, Hancock NC, Gao C, Ishii K, Markulić J, Parker MW. Biophys Rev 14 233-255 (2022)
- The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer's Disease. Busch L, Eggert S, Endres K, Bufe B. Cells 11 3421 (2022)
- Computer Aided Drug Design Methodologies with Natural Products in the Drug Research Against Alzheimer's Disease. de Sousa NF, Scotti L, de Moura ÉP, Dos Santos Maia M, Rodrigues GCS, de Medeiros HIR, Lopes SM, Scotti MT. Curr Neuropharmacol 20 857-885 (2022)
- Current understanding of metal-dependent amyloid-β aggregation and toxicity. Yi Y, Lim MH. RSC Chem Biol 4 121-131 (2023)
- Big versus small: The impact of aggregate size in disease. Hnath B, Chen J, Reynolds J, Choi E, Wang J, Zhang D, Sha CM, Dokholyan NV. Protein Sci 32 e4686 (2023)
- The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer's Disease. Ehtezazi T, Rahman K, Davies R, Leach AG. J Alzheimers Dis Rep 7 173-211 (2023)
Articles - 1iyt mentioned but not cited (121)
- Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, Spencer B, Rockenstein E, Trejo M, Platoshyn O, Yuan JX, Masliah E. PLoS One 3 e3135 (2008)
- Comparison of force fields for Alzheimer's A β42: A case study for intrinsically disordered proteins. Carballo-Pacheco M, Strodel B. Protein Sci 26 174-185 (2017)
- Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases. Alam P, Chaturvedi SK, Siddiqi MK, Rajpoot RK, Ajmal MR, Zaman M, Khan RH, Khan RH. Sci Rep 6 26759 (2016)
- Plasticity of influenza haemagglutinin fusion peptides and their interaction with lipid bilayers. Vaccaro L, Cross KJ, Kleinjung J, Straus SK, Thomas DJ, Wharton SA, Skehel JJ, Fraternali F. Biophys J 88 25-36 (2005)
- Molecular Dynamics Simulations of Amyloid β-Peptide (1-42): Tetramer Formation and Membrane Interactions. Brown AM, Bevan DR. Biophys J 111 937-949 (2016)
- Alzheimer Aβ peptide interactions with lipid membranes: fibrils, oligomers and polymorphic amyloid channels. Tofoleanu F, Buchete NV. Prion 6 339-345 (2012)
- Binding of β-amyloid (1-42) peptide to negatively charged phospholipid membranes in the liquid-ordered state: modeling and experimental studies. Ahyayauch H, Raab M, Busto JV, Andraka N, Arrondo JR, Masserini M, Tvaroska I, Goñi FM. Biophys J 103 453-463 (2012)
- The interaction between amyloid-β peptides and anionic lipid membranes containing cholesterol and melatonin. Dies H, Toppozini L, Rheinstädter MC. PLoS One 9 e99124 (2014)
- Simultaneous prediction of protein secondary structure and transmembrane spans. Leman JK, Mueller R, Karakas M, Woetzel N, Meiler J. Proteins 81 1127-1140 (2013)
- Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce Tau missorting. Schützmann MP, Hasecke F, Bachmann S, Zielinski M, Hänsch S, Schröder GF, Zempel H, Hoyer W. Nat Commun 12 4634 (2021)
- Aspirin-Mediated Acetylation Protects Against Multiple Neurodegenerative Pathologies by Impeding Protein Aggregation. Ayyadevara S, Balasubramaniam M, Kakraba S, Alla R, Mehta JL, Shmookler Reis RJ. Antioxid Redox Signal 27 1383-1396 (2017)
- Atomic and dynamic insights into the beneficial effect of the 1,4-naphthoquinon-2-yl-L-tryptophan inhibitor on Alzheimer's Aβ1-42 dimer in terms of aggregation and toxicity. Zhang T, Zhang T, Xu W, Mu Y, Derreumaux P. ACS Chem Neurosci 5 148-159 (2014)
- Molecular plasticity regulates oligomerization and cytotoxicity of the multipeptide-length amyloid-β peptide pool. Vandersteen A, Masman MF, De Baets G, Jonckheere W, van der Werf K, Marrink SJ, Rozenski J, Benilova I, De Strooper B, Subramaniam V, Schymkowitz J, Rousseau F, Broersen K. J Biol Chem 287 36732-36743 (2012)
- Crystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumab. Feinberg H, Saldanha JW, Diep L, Goel A, Widom A, Veldman GM, Weis WI, Schenk D, Basi GS. Alzheimers Res Ther 6 31 (2014)
- New insight into Alzheimer's disease: Light reverses Aβ-obstructed interstitial fluid flow and ameliorates memory decline in APP/PS1 mice. Yue X, Mei Y, Zhang Y, Tong Z, Cui D, Yang J, Wang A, Wang R, Fei X, Ai L, Di Y, Luo H, Li H, Luo W, Lu Y, Li R, Duan C, Gao G, Yang H, Sun B, He R, Song W, Han H, Tong Z. Alzheimers Dement (N Y) 5 671-684 (2019)
- Computational and experimental studies on β-sheet breakers targeting Aβ1-40 fibrils. Minicozzi V, Chiaraluce R, Consalvi V, Giordano C, Narcisi C, Punzi P, Rossi GC, Morante S. J Biol Chem 289 11242-11252 (2014)
- Disease-modifying anti-Alzheimer's drugs: inhibitors of human cholinesterases interfering with β-amyloid aggregation. Brogi S, Butini S, Maramai S, Colombo R, Verga L, Lanni C, De Lorenzi E, Lamponi S, Andreassi M, Bartolini M, Andrisano V, Novellino E, Campiani G, Brindisi M, Gemma S. CNS Neurosci Ther 20 624-632 (2014)
- Self-assembly of the full-length amyloid Aβ42 protein in dimers. Zhang Y, Hashemi M, Lv Z, Lyubchenko YL. Nanoscale 8 18928-18937 (2016)
- Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs. Kumar R, Nordberg A, Darreh-Shori T. Brain 139 174-192 (2016)
- Extracellular interface between APP and Nicastrin regulates Aβ length and response to γ-secretase modulators. Petit D, Hitzenberger M, Lismont S, Zoltowska KM, Ryan NS, Mercken M, Bischoff F, Zacharias M, Chávez-Gutiérrez L. EMBO J 38 e101494 (2019)
- Monomeric Amyloid Beta Peptide in Hexafluoroisopropanol Detected by Small Angle Neutron Scattering. Zhang-Haagen B, Biehl R, Nagel-Steger L, Radulescu A, Richter D, Willbold D. PLoS One 11 e0150267 (2016)
- Why does the Aβ peptide of Alzheimer share structural similarity with antimicrobial peptides? Pastore A, Raimondi F, Rajendran L, Temussi PA. Commun Biol 3 135 (2020)
- A Novel Nanosystem Realizing Curcumin Delivery Based on Fe3O4@Carbon Dots Nanocomposite for Alzheimer's Disease Therapy. Kuang Y, Zhang J, Xiong M, Zeng W, Lin X, Yi X, Luo Y, Yang M, Li F, Huang Q. Front Bioeng Biotechnol 8 614906 (2020)
- Unraveling Comparative Anti-Amyloidogenic Behavior of Pyrazinamide and D-Cycloserine: A Mechanistic Biophysical Insight. Chaturvedi SK, Zaidi N, Alam P, Khan JM, Qadeer A, Siddique IA, Asmat S, Zaidi Y, Khan RH. PLoS One 10 e0136528 (2015)
- The flavonoid derivative 2-(4' Benzyloxyphenyl)-3-hydroxy-chromen-4-one protects against Aβ42-induced neurodegeneration in transgenic Drosophila: insights from in silico and in vivo studies. Singh SK, Gaur R, Kumar A, Fatima R, Mishra L, Srikrishna S. Neurotox Res 26 331-350 (2014)
- Amyloid-β oligomerization monitored by single-molecule stepwise photobleaching. Dresser L, Hunter P, Yendybayeva F, Hargreaves AL, Howard JAL, Evans GJO, Leake MC, Quinn SD. Methods 193 80-95 (2021)
- Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease. Lan JS, Hou JW, Liu Y, Ding Y, Zhang Y, Li L, Zhang T. J Enzyme Inhib Med Chem 32 776-788 (2017)
- Structural diversity of Alzheimer's disease amyloid-β dimers and their role in oligomerization and fibril formation. Tsigelny IF, Sharikov Y, Kouznetsova VL, Greenberg JP, Wrasidlo W, Gonzalez T, Desplats P, Michael SE, Trejo-Morales M, Overk CR, Masliah E. J Alzheimers Dis 39 583-600 (2014)
- N-alkyl carbazole derivatives as new tools for Alzheimer's disease: preliminary studies. Saturnino C, Iacopetta D, Sinicropi MS, Rosano C, Caruso A, Caporale A, Marra N, Marengo B, Pronzato MA, Parisi OI, Longo P, Ricciarelli R. Molecules 19 9307-9317 (2014)
- Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study. Doytchinova I, Atanasova M, Salamanova E, Ivanov S, Dimitrov I. Biomolecules 10 E1323 (2020)
- A lowly populated, transient β-sheet structure in monomeric Aβ1-42 identified by multinuclear NMR of chemical denaturation. Kakeshpour T, Ramanujam V, Barnes CA, Shen Y, Ying J, Bax A. Biophys Chem 270 106531 (2021)
- Aggregation States of Aβ1-40, Aβ1-42 and Aβp3-42 Amyloid Beta Peptides: A SANS Study. Festa G, Mallamace F, Sancesario GM, Corsaro C, Mallamace D, Fazio E, Arcidiacono L, Garcia Sakai V, Senesi R, Preziosi E, Sancesario G, Andreani C. Int J Mol Sci 20 E4126 (2019)
- Embedding Aβ42 in heterogeneous membranes depends on cholesterol asymmetries. Liguori N, Nerenberg PS, Head-Gordon T. Biophys J 105 899-910 (2013)
- Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus: From docking Modeling to Protection Against Neurotoxicity in Alzheimer's disease. Picón-Pagès P, Bonet J, García-García J, Garcia-Buendia J, Gutierrez D, Valle J, Gómez-Casuso CES, Sidelkivska V, Alvarez A, Perálvarez-Marín A, Suades A, Fernàndez-Busquets X, Andreu D, Vicente R, Oliva B, Muñoz FJ. Comput Struct Biotechnol J 17 963-971 (2019)
- 9-Methylfascaplysin Is a More Potent Aβ Aggregation Inhibitor than the Marine-Derived Alkaloid, Fascaplysin, and Produces Nanomolar Neuroprotective Effects in SH-SY5Y Cells. Sun Q, Liu F, Sang J, Lin M, Ma J, Xiao X, Yan S, Naman CB, Wang N, He S, Yan X, Cui W, Liang H. Mar Drugs 17 E121 (2019)
- Design and Synthesis of Novel Hybrid 8-Hydroxy Quinoline-Indole Derivatives as Inhibitors of Aβ Self-Aggregation and Metal Chelation-Induced Aβ Aggregation. Bowroju SK, Mainali N, Ayyadevara S, Penthala NR, Krishnamachari S, Kakraba S, Reis RJS, Crooks PA. Molecules 25 E3610 (2020)
- Design, synthesis and evaluation of quinolinone derivatives containing dithiocarbamate moiety as multifunctional AChE inhibitors for the treatment of Alzheimer's disease. Fu J, Bao F, Gu M, Liu J, Zhang Z, Ding J, Xie SS, Ding J. J Enzyme Inhib Med Chem 35 118-128 (2020)
- Modeling the Aggregation Propensity and Toxicity of Amyloid-β Variants. Tiwari MK, Kepp KP. J Alzheimers Dis 47 215-229 (2015)
- Plant-Derived Natural Biomolecule Picein Attenuates Menadione Induced Oxidative Stress on Neuroblastoma Cell Mitochondria. Kesari KK, Dhasmana A, Shandilya S, Prabhakar N, Shaukat A, Dou J, Rosenholm JM, Vuorinen T, Ruokolainen J. Antioxidants (Basel) 9 E552 (2020)
- Predicting Genetic Variation Severity Using Machine Learning to Interpret Molecular Simulations. McCoy MD, Hamre J, Klimov DK, Jafri MS. Biophys J 120 189-204 (2021)
- Prediction of Transmembrane Regions, Cholesterol, and Ganglioside Binding Sites in Amyloid-Forming Proteins Indicate Potential for Amyloid Pore Formation. Venko K, Novič M, Stoka V, Žerovnik E. Front Mol Neurosci 14 619496 (2021)
- A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth. Shi XL, Yan N, Cui YJ, Liu ZP. Cells 9 E649 (2020)
- Exploring the Early Stages of the Amyloid Aβ(1-42) Peptide Aggregation Process: An NMR Study. Santoro A, Grimaldi M, Buonocore M, Stillitano I, D'Ursi AM. Pharmaceuticals (Basel) 14 732 (2021)
- In silico and in vitro studies to elucidate the role of Cu2+ and galanthamine as the limiting step in the amyloid beta (1-42) fibrillation process. Hernández-Rodríguez M, Correa-Basurto J, Benitez-Cardoza CG, Resendiz-Albor AA, Rosales-Hernández MC. Protein Sci 22 1320-1335 (2013)
- Mimosine functionalized gold nanoparticles (Mimo-AuNPs) suppress β-amyloid aggregation and neuronal toxicity. Anand BG, Wu Q, Karthivashan G, Shejale KP, Amidian S, Wille H, Kar S. Bioact Mater 6 4491-4505 (2021)
- The Position of Aβ22-40 and Aβ1-42 in Anionic Lipid Membranes Containing Cholesterol. Barrett MA, Alsop RJ, Hauß T, Rheinstädter MC. Membranes (Basel) 5 824-843 (2015)
- Transport of Alzheimer's associated amyloid-β catalyzed by P-glycoprotein. McCormick JW, Ammerman L, Chen G, Vogel PD, Wise JG. PLoS One 16 e0250371 (2021)
- Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended In Cellulo, In Silico, and Kinetic Studies of Multifunctional Anti-Alzheimer's Agents. Pasieka A, Panek D, Szałaj N, Espargaró A, Więckowska A, Malawska B, Sabaté R, Bajda M. ACS Chem Neurosci 12 2057-2068 (2021)
- Effects of Curcumin and Ferulic Acid on the Folding of Amyloid-β Peptide. Salamanova E, Atanasova M, Dimitrov I, Doytchinova I. Molecules 26 2815 (2021)
- Mutation-based structural modification and dynamics study of amyloid beta peptide (1-42): An in-silico-based analysis to cognize the mechanism of aggregation. Panda PK, Patil AS, Patel P, Panchal H. Genom Data 7 189-194 (2016)
- Packing Density of the Amyloid Precursor Protein in the Cell Membrane. de Coninck D, Schmidt TH, Schloetel JG, Lang T. Biophys J 114 1128-1141 (2018)
- Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions. Cieplak AS. PLoS One 12 e0180905 (2017)
- Rhodamine-Based Metal Chelator: A Potent Inhibitor of Metal-Catalyzed Amyloid Toxicity. Pradhan K, Das G, Kar C, Mukherjee N, Khan J, Mahata T, Barman S, Ghosh S. ACS Omega 5 18958-18967 (2020)
- Analysis of conformational variation in macromolecular structural models. Srivastava SK, Srivastava SK, Gayathri S, Manjasetty BA, Gopal B. PLoS One 7 e39993 (2012)
- Boldine Attenuates Synaptic Failure and Mitochondrial Deregulation in Cellular Models of Alzheimer's Disease. Toledo JP, Fernández-Pérez EJ, Ferreira IL, Marinho D, Riffo-Lepe NO, Pineda-Cuevas BN, Pinochet-Pino LF, Burgos CF, Rego AC, Aguayo LG. Front Neurosci 15 617821 (2021)
- Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures. Sablón-Carrazana M, Fernández I, Bencomo A, Lara-Martínez R, Rivera-Marrero S, Domínguez G, Pérez-Perera R, Jiménez-García LF, Altamirano-Bustamante NF, Diaz-Delgado M, Vedrenne F, Rivillas-Acevedo L, Pasten-Hidalgo K, Segura-Valdez Mde L, Islas-Andrade S, Garrido-Magaña E, Perera-Pintado A, Prats-Capote A, Rodríguez-Tanty C, Altamirano-Bustamante MM. PLoS One 10 e0135292 (2015)
- Long-range Regulation of Partially Folded Amyloidogenic Peptides. Bhattacharya S, Xu L, Thompson D. Sci Rep 10 7597 (2020)
- Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies. Maiti P, Manna J, Thammathong J, Evans B, Dubey KD, Banerjee S, Dunbar GL. Antioxidants (Basel) 10 1592 (2021)
- Tryptophan-Containing Dual Neuroprotective Peptides: Prolyl Endopeptidase Inhibition and Caenorhabditis elegans Protection from β-Amyloid Peptide Toxicity. Manzanares P, Martínez R, Garrigues S, Genovés S, Ramón D, Marcos JF, Martorell P. Int J Mol Sci 19 (2018)
- Aggregation Mechanism of Alzheimer's Amyloid β-Peptide Mediated by α-Strand/α-Sheet Structure. Balupuri A, Choi KE, Kang NS. Int J Mol Sci 21 E1094 (2020)
- Allosteric Binding Sites of Aβ Peptides on the Acetylcholine Synthesizing Enzyme ChAT as Deduced by In Silico Molecular Modeling. Baidya AT, Kumar A, Kumar R, Darreh-Shori T. Int J Mol Sci 23 6073 (2022)
- Azobioisosteres of Curcumin with Pronounced Activity against Amyloid Aggregation, Intracellular Oxidative Stress, and Neuroinflammation. Hofmann J, Ginex T, Espargaró A, Scheiner M, Gunesch S, Aragó M, Stigloher C, Sabaté R, Luque FJ, Decker M. Chemistry 27 6015-6027 (2021)
- Computational Studies of Beta Amyloid (Aβ42) with p75NTR Receptor: A Novel Therapeutic Target in Alzheimer's Disease. Devarajan S, Sharmila JS. Adv Bioinformatics 2014 736378 (2014)
- Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer's Disease: From In Silico to In Vivo. Stern N, Gacs A, Tátrai E, Flachner B, Hajdú I, Dobi K, Bágyi I, Dormán G, Lőrincz Z, Cseh S, Kígyós A, Tóvári J, Goldblum A. Int J Mol Sci 23 13098 (2022)
- Effect of the air-water interface on the conformation of amyloid beta. Samantray S, Cheung DL. Biointerphases 15 061011 (2020)
- In Silico Analysis of Metabolites from Peruvian Native Plants as Potential Therapeutics against Alzheimer's Disease. Goyzueta-Mamani LD, Barazorda-Ccahuana HL, Chávez-Fumagalli MA, F Alvarez KL, Aguilar-Pineda JA, Vera-Lopez KJ, Lino Cardenas CL. Molecules 27 918 (2022)
- In Silico Analysis of the Antagonist Effect of Enoxaparin on the ApoE4-Amyloid-Beta (Aβ) Complex at Different pH Conditions. Aguilar-Pineda JA, Paco-Coralla SG, Febres-Molina C, Gamero-Begazo PL, Shrivastava P, Vera-López KJ, Davila-Del-Carpio G, López-C P, Gómez B, Lino Cardenas CL. Biomolecules 12 499 (2022)
- Structure modeling and dynamics driven mutation and phosphorylation analysis of Beta-amyloid peptides. Singh SK, Singh A, Prakash V, C SK. Bioinformation 10 569-574 (2014)
- Tyrosine Rotamer States in Beta Amyloid: Signatures of Aggregation and Fibrillation. Mancini O, Rolinski OJ, Kubiak-Ossowska K, Mulheran PA. ACS Omega 3 16046-16056 (2018)
- Elaboration of the Effective Multi-Target Therapeutic Platform for the Treatment of Alzheimer's Disease Based on Novel Monoterpene-Derived Hydroxamic Acids. Aleksandrova Y, Munkuev A, Mozhaitsev E, Suslov E, Tsypyshev D, Chaprov K, Begunov R, Volcho K, Salakhutdinov N, Neganova M. Int J Mol Sci 24 9743 (2023)
- How Does the Mono-Triazole Derivative Modulate Aβ42 Aggregation and Disrupt a Protofibril Structure: Insights from Molecular Dynamics Simulations. Kaur A, Kaur A, Goyal D, Goyal B. ACS Omega 5 15606-15619 (2020)
- Inhibition Mechanisms of (-)-Epigallocatechin-3-gallate and Genistein on Amyloid-beta 42 Peptide of Alzheimer's Disease via Molecular Simulations. Fang M, Zhang Q, Wang X, Su K, Guan P, Hu X. ACS Omega 7 19665-19675 (2022)
- Inhibition of aggregation of amyloid-β through covalent modification with benzylpenicillin; potential relevance to Alzheimer's disease. Alsalahat I, Al-Majdoub ZM, Taha MO, Barber J, Aojula H, Hodson N, Freeman S. Biochem Biophys Rep 26 100943 (2021)
- Monosialotetrahexosylganglioside Promotes Early Aβ42 Oligomer Formation and Maintenance. Zhang DY, Wang J, Fleeman RM, Kuhn MK, Swulius MT, Proctor EA, Dokholyan NV. ACS Chem Neurosci 13 1979-1991 (2022)
- Simulations of cross-amyloid aggregation of amyloid-β and islet amyloid polypeptide fragments. Kawecki GE, King KM, Cramer NA, Bevan DR, Brown AM. Biophys J 121 2002-2013 (2022)
- Synthesis of novel 4-methylthiocoumarin and comparison with conventional coumarin derivative as a multi-target-directed ligand in Alzheimer's disease. Kumar S, Tyagi YK, Kumar M, Kumar S. 3 Biotech 10 509 (2020)
- Virtual screening following rational drug design based approach for introducing new anti amyloid beta aggregation agent. Rigi G, Nakhaei MVA, Eidipour H, Najimi A, Tajik F, Taher N, Yarahmadi K. Bioinformation 13 42-45 (2017)
- Anti-Aggregation Property of Allicin by In Vitro and Molecular Docking Studies. Kumar S, Kumar S, Ram H. J Exp Neurosci 13 1179069519866185 (2019)
- Bio-Evaluation of 99mTc-Labeled Homodimeric Chalcone Derivative as Amyloid-β-Targeting Probe. Mann G, Chauhan K, Kumar V, Daksh S, Kumar N, Thirumal M, Datta A. Front Med (Lausanne) 9 813465 (2022)
- Click-designed vanilloid-triazole conjugates as dual inhibitors of AChE and Aβ aggregation. Elsbaey M, Igarashi Y, Ibrahim MAA, Elattar E. RSC Adv 13 2871-2883 (2023)
- Conformational Transitions of Amyloid-β: A Langevin and Generalized Langevin Dynamics Simulation Study. Singh V, Biswas P. ACS Omega 6 13611-13619 (2021)
- Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease. Makhaeva GF, Kovaleva NV, Rudakova EV, Boltneva NP, Grishchenko MV, Lushchekina SV, Astakhova TY, Serebryakova OG, Timokhina EN, Zhilina EF, Shchegolkov EV, Ulitko MV, Radchenko EV, Palyulin VA, Burgart YV, Saloutin VI, Bachurin SO, Richardson RJ. Int J Mol Sci 24 2285 (2023)
- Data Mining of Molecular Simulations Suggest Key Amino Acid Residues for Aggregation, Signaling and Drug Action. Gurunathan V, Hamre J, Klimov DK, Jafri MS. Biomolecules 11 1541 (2021)
- Design and Experimental Evaluation of a Peptide Antagonist against Amyloid β(1-42) Interactions with Calmodulin and Calbindin-D28k. Salazar J, Poejo J, Mata AM, Samhan-Arias AK, Gutierrez-Merino C. Int J Mol Sci 23 2289 (2022)
- Development of novel N-(6-methanesulfonyl-benzothiazol-2-yl)-3-(4-substituted-piperazin-1-yl)-propionamides with cholinesterase inhibition, anti-β-amyloid aggregation, neuroprotection and cognition enhancing properties for the therapy of Alzheimer's disease. Mishra CB, Shalini S, Gusain S, Prakash A, Kumari J, Kumari S, Yadav AK, Lynn AM, Tiwari M. RSC Adv 10 17602-17619 (2020)
- Effects of a plant cyclotide on conformational dynamics and destabilization of β-amyloid fibrils through molecular dynamics simulations. Kalmankar NV, Gehi BR, Sowdhamini R. Front Mol Biosci 9 986704 (2022)
- Heptameric Peptide Interferes with Amyloid-β Aggregation by Structural Reorganization of the Toxic Oligomers. Bhattacharyya R, Bhattacharjee S, Pathak BK, Sengupta J. ACS Omega 5 16128-16138 (2020)
- Human Serum Albumin-Inspired Glycopeptide-Based Multifunctional Inhibitor of Amyloid-β Toxicity. Roy R, Pradhan K, Khan J, Das G, Mukherjee N, Das D, Ghosh S. ACS Omega 5 18628-18641 (2020)
- Inhibition of amyloid β1-42 peptide aggregation by newly designed cyclometallated palladium complexes. Saini R, Navale GR, Singh S, Singh HK, Chauhan R, Agrawal S, Sarkar D, Sarma M, Ghosh K. Int J Biol Macromol 248 125847 (2023)
- NMR structure of the water soluble Aβ17-34 peptide. Fonar G, Samson AO. Biosci Rep 34 e00155 (2014)
- New amyloid beta-disaggregating agents: synthesis, pharmacological evaluation, crystal structure and molecular docking of N-(4-((7-chloroquinolin-4-yl)oxy)-3-ethoxybenzyl)amines. Umar T, Shalini S, Raza MK, Gusain S, Kumar J, Ahmed W, Tiwari M, Hoda N. Medchemcomm 9 1891-1904 (2018)
- Oligomerization Alters Binding Affinity Between Amyloid Beta and a Modulator of Peptide Aggregation. Hilt S, Rojalin T, Viitala T, Koivuniemi A, Bunker A, Hogiu SW, Kálai T, Hideg K, Yliperttula M, Voss JC. J Phys Chem C Nanomater Interfaces 121 23974-23987 (2017)
- Orientation of tyrosine side chain in neurotoxic Aβ differs in two different secondary structures of the peptide. Das S, Das S, Roy A, Pal U, Maiti NC. R Soc Open Sci 3 160112 (2016)
- RRY Inhibits Amyloid-β1-42 Peptide Aggregation and Neurotoxicity. Sun X, Duan S, Cao A, Villagomez B, Lin R, Chen H, Pi L, Ren B, Chen R, Chen M, Ying Z, Fang S, Cao Q. J Alzheimers Dis Rep 5 479-495 (2021)
- Residue Interaction Network Analysis Predicts a Val24-Ile31 Interaction May be Involved in Preventing Amyloid-Beta (1-42) Primary Nucleation. Griffin JWD, Bradshaw PC. Protein J 40 175-183 (2021)
- Single Point Mutation from E22-to-K in Aβ Initiates Early-Onset Alzheimer's Disease by Binding with Catalase. Jiang W, YanYu, Yao D, Fei X, Ai L, Di Y, Zhang J, Yue X, Zhao S, He R, Lyu J, Tong Z. Oxid Med Cell Longev 2020 4981204 (2020)
- Study of Biomolecular Interactions of Mitochondrial Proteins Related to Alzheimer's Disease: Toward Multi-Interaction Biomolecular Processes. Hemmerová E, Špringer T, Krištofiková Z, Homola J. Biomolecules 10 E1214 (2020)
- Systematic Review The cellular model for Alzheimer's disease research: PC12 cells. Xie D, Deng T, Zhai Z, Sun T, Xu Y. Front Mol Neurosci 15 1016559 (2022)
- [18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations. Rivera-Marrero S, Fernández-Maza L, León-Chaviano S, Sablón-Carrazana M, Bencomo-Martínez A, Perera-Pintado A, Prats-Capote A, Zoppolo F, Kreimerman I, Pardo T, Reyes L, Balcerzyk M, Dubed-Bandomo G, Mercerón-Martínez D, Espinosa-Rodríguez LA, Engler H, Savio E, Rodríguez-Tanty C. Curr Radiopharm 12 58-71 (2019)
- A computational study of metal ions interaction with amyloid-β 1-42 peptide structure in hyperpyrexia: Implications for Alzheimer disease. Mocanu CS, Darie-Ion L, Petre BA, Gradinaru VR, Drochioiu G. J King Saud Univ Sci 34 102184 (2022)
- An Electrochemistry and Computational Study at an Electrified Liquid-Liquid Interface for Studying Beta-Amyloid Aggregation. Silwane B, Wilson M, Kataky R. Membranes (Basel) 13 584 (2023)
- Computational screening for new neuroprotective ingredients against Alzheimer's disease from bilberry by cheminformatics approaches. Xiao R, Liang R, Cai YH, Dong J, Zhang L. Front Nutr 9 1061552 (2022)
- Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer's disease. Makhaeva GF, Kovaleva NV, Rudakova EV, Boltneva NP, Lushchekina SV, Astakhova TY, Timokhina EN, Serebryakova OG, Shchepochkin AV, Averkov MA, Utepova IA, Demina NS, Radchenko EV, Palyulin VA, Fisenko VP, Bachurin SO, Chupakhin ON, Charushin VN, Richardson RJ. Front Pharmacol 14 1219980 (2023)
- Design and synthesis of piano-stool ruthenium(II) complexes and their studies on the inhibition of amyloid β (1-42) peptide aggregation. Singh S, Navale GR, Agrawal S, Singh HK, Singla L, Sarkar D, Sarma M, Choudhury AR, Ghosh K. Int J Biol Macromol 239 124197 (2023)
- Effect of C-terminus amidation of Aβ39-42 fragment derived peptides as potential inhibitors of Aβ aggregation. Kapadia A, Patel A, Sharma KK, Maurya IK, Singh V, Khullar M, Jain R. RSC Adv 10 27137-27151 (2020)
- Effects of Familial Alzheimer's Disease Mutations on the Folding Free Energy and Dipole-Dipole Interactions of the Amyloid β-Peptide. Davidson DS, Kraus JA, Montgomery JM, Lemkul JA. J Phys Chem B 126 7552-7566 (2022)
- Experimental and hypothetical appraisal on inhibition of glucose-induced glycation of bovine serum albumin by quercetin. Oso BJ, Olaoye I, Oso OT. J Genet Eng Biotechnol 21 123 (2023)
- Fluorescence-Labeled Amyloid Beta Monomer: A Molecular Dynamical Study. Gera J, Paragi G. Molecules 25 E3524 (2020)
- Glycation Inhibition of Bovine Serum Albumin by Extracts of Momordica charantia L. using Spectroscopic and Computational Methods. Oso B, Agboola O, Olaoye I. Avicenna J Med Biotechnol 15 180-187 (2023)
- In-silico structural analysis of Heterocephalus glaber amyloid beta: an anti-Alzheimer's peptide. Javanmard A, Azimzadeh-Irani M, Tafazzoli G, Esmaeilzadeh A, Shirinpoor-Kharf M, Haghayeghi SMH. Mol Biol Res Commun 13 29-42 (2024)
- Inhibition Effect and Molecular Mechanisms of Quercetin on the Aβ42 Dimer: A Molecular Dynamics Simulation Study. Fang M, Wang X, Su K, Jia X, Guan P, Hu X. ACS Omega 8 18009-18018 (2023)
- Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors. Aloufi B, Alshammari AM, Alshammari N, Alam MJ. Bioinformation 18 622-629 (2022)
- Molecular mechanisms of amyloid-β peptide fibril and oligomer formation: NMR-based challenges. Hiroaki H. Biophys Physicobiol 20 e200007 (2023)
- Novel Design of Neuropeptide-Based Drugs with β-Sheet Breaking Potential in Amyloid-Beta Cascade: Molecular and Structural Deciphers. Mocanu CS, Niculaua M, Zbancioc G, Mangalagiu V, Drochioiu G. Int J Mol Sci 23 2857 (2022)
- Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer's disease. Du H, Song J, Ma F, Gao H, Zhao X, Mao R, He X, Yan Y. J Enzyme Inhib Med Chem 38 2281893 (2023)
- Presenilin-1-Derived Circular RNAs: Neglected Epigenetic Regulators with Various Functions in Alzheimer's Disease. Sanadgol N, Amini J, Beyer C, Zendedel A. Biomolecules 13 1401 (2023)
- Sterol-activated amyloid beta fibril formation. Cook I, Leyh TS. J Biol Chem 299 105445 (2023)
- Summary of the Current Status of DNA Vaccination for Alzheimer Disease. Vicidomini C, Borbone N, Roviello V, Roviello GN, Oliviero G. Vaccines (Basel) 11 1706 (2023)
- Synthesis and properties of the kojic acid dimer and its potential for the treatment of Alzheimer's disease. Liu X, Yu C, Su B, Zha D. RSC Med Chem 14 268-276 (2023)
- Toward the Noninvasive Diagnosis of Alzheimer's Disease: Molecular Basis for the Specificity of Curcumin for Fibrillar Amyloid-β. Khurshid B, Rehman AU, Muhammad S, Wadood A, Anwar J. ACS Omega 7 22032-22038 (2022)
- Towards mechanistic models of mutational effects: Deep learning on Alzheimer's Aβ peptide. Wang B, Razavi S, Gamazon ER. Comput Struct Biotechnol J 21 2434-2445 (2023)
Reviews citing this publication (25)
- Amyloid-beta aggregation. Finder VH, Glockshuber R. Neurodegener Dis 4 13-27 (2007)
- Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Harauz G, Ishiyama N, Hill CM, Bates IR, Libich DS, Farès C. Micron 35 503-542 (2004)
- The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from type II diabetes. Hebda JA, Miranker AD. Annu Rev Biophys 38 125-152 (2009)
- Implications of peptide assemblies in amyloid diseases. Ke PC, Sani MA, Ding F, Kakinen A, Javed I, Separovic F, Davis TP, Mezzenga R. Chem Soc Rev 46 6492-6531 (2017)
- Antimicrobial properties of amyloid peptides. Kagan BL, Jang H, Capone R, Teran Arce F, Ramachandran S, Lal R, Nussinov R. Mol Pharm 9 708-717 (2012)
- From Alzheimer to Huntington: why is a structural understanding so difficult? Temussi PA, Masino L, Pastore A. EMBO J 22 355-361 (2003)
- Structure and function of amyloid in Alzheimer's disease. Morgan C, Colombres M, Nuñez MT, Inestrosa NC. Prog Neurobiol 74 323-349 (2004)
- Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships? Beel AJ, Sakakura M, Barrett PJ, Sanders CR. Biochim Biophys Acta 1801 975-982 (2010)
- Coarse-grained models for protein aggregation. Wu C, Shea JE. Curr Opin Struct Biol 21 209-220 (2011)
- Strategies for the inhibition of protein aggregation in human diseases. Bartolini M, Andrisano V. Chembiochem 11 1018-1035 (2010)
- Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs. Jang H, Arce FT, Ramachandran S, Kagan BL, Lal R, Nussinov R. Chem Soc Rev 43 6750-6764 (2014)
- What is the dominant Abeta species in human brain tissue? A review. Gregory GC, Halliday GM. Neurotox Res 7 29-41 (2005)
- D-amino acid-based peptide inhibitors as early or preventative therapy in Alzheimer disease. Kumar J, Sim V. Prion 8 119-124 (2014)
- Functional Reciprocity of Amyloids and Antimicrobial Peptides: Rethinking the Role of Supramolecular Assembly in Host Defense, Immune Activation, and Inflammation. Lee EY, Srinivasan Y, de Anda J, Nicastro LK, Tükel Ç, Wong GCL. Front Immunol 11 1629 (2020)
- Towards a true protein movie: a perspective on the potential impact of the ensemble-based structure determination using exact NOEs. Vögeli B, Orts J, Strotz D, Chi C, Minges M, Wälti MA, Güntert P, Riek R. J Magn Reson 241 53-59 (2014)
- Strategies for dealing with conformational sampling in structural calculations of flexible or kinked transmembrane peptides. Rainey JK, Fliegel L, Sykes BD. Biochem Cell Biol 84 918-929 (2006)
- Apolipoprotein Abeta: black sheep in a good family. Kontush A. Brain Pathol 14 433-447 (2004)
- Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer's Disease Development. Urban AS, Pavlov KV, Kamynina AV, Okhrimenko IS, Arseniev AS, Bocharov EV. Molecules 26 2897 (2021)
- Structure and Function of Alzheimer's Amyloid βeta Proteins from Monomer to Fibrils: A Mini Review. Agrawal N, Skelton AA. Protein J 38 425-434 (2019)
- Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer's Disease. Mamsa SSA, Meloni BP. Front Mol Neurosci 14 759729 (2021)
- When "IUPs" were "BAPs": How to study the nonconformation of intrinsically unfolded polyaminoacid chains. Pastore A, Temussi P. Biopolymers 100 592-600 (2013)
- Impact of a discordant helix on β-amyloid structure, aggregation ability and toxicity. Chen YC. Eur Biophys J 46 681-687 (2017)
- Physical Chemistry of the Protein Backbone: Enabling the Mechanisms of Intrinsic Protein Disorder. Drake JA, Pettitt BM. J Phys Chem B 124 4379-4390 (2020)
- Amyloid beta and its naturally occurring N-terminal variants are potent activators of human and mouse formyl peptide receptor 1. Busch L, Al Taleb Z, Tsai YL, Nguyen VTT, Lu Q, Synatschke CV, Endres K, Bufe B. J Biol Chem 298 102642 (2022)
- Amyloidogenicity at a Distance: How Distal Protein Regions Modulate Aggregation in Disease. Lucato CM, Lupton CJ, Halls ML, Ellisdon AM. J Mol Biol 429 1289-1304 (2017)
Articles citing this publication (188)
- The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. Tomaselli S, Esposito V, Vangone P, van Nuland NA, Bonvin AM, Guerrini R, Tancredi T, Temussi PA, Picone D. Chembiochem 7 257-267 (2006)
- In silico study of amyloid beta-protein folding and oligomerization. Urbanc B, Cruz L, Yun S, Buldyrev SV, Bitan G, Teplow DB, Stanley HE. Proc Natl Acad Sci U S A 101 17345-17350 (2004)
- Elucidation of amyloid beta-protein oligomerization mechanisms: discrete molecular dynamics study. Urbanc B, Betnel M, Cruz L, Bitan G, Teplow DB. J Am Chem Soc 132 4266-4280 (2010)
- Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differences. Yang M, Teplow DB. J Mol Biol 384 450-464 (2008)
- Amyloid beta-protein monomer structure: a computational and experimental study. Baumketner A, Bernstein SL, Wyttenbach T, Bitan G, Teplow DB, Bowers MT, Shea JE. Protein Sci 15 420-428 (2006)
- Molecular dynamics simulation of amyloid beta dimer formation. Urbanc B, Cruz L, Ding F, Sammond D, Khare S, Buldyrev SV, Stanley HE, Dokholyan NV. Biophys J 87 2310-2321 (2004)
- Calcium-dependent open/closed conformations and interfacial energy maps of reconstituted hemichannels. Thimm J, Mechler A, Lin H, Rhee S, Lal R. J Biol Chem 280 10646-10654 (2005)
- Structural basis of Notch recognition by human γ-secretase. Yang G, Zhou R, Zhou Q, Guo X, Yan C, Ke M, Lei J, Shi Y. Nature 565 192-197 (2019)
- Structure and dynamics of the Abeta(21-30) peptide from the interplay of NMR experiments and molecular simulations. Fawzi NL, Phillips AH, Ruscio JZ, Doucleff M, Wemmer DE, Head-Gordon T. J Am Chem Soc 130 6145-6158 (2008)
- Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy. Nanga RP, Brender JR, Xu J, Veglia G, Ramamoorthy A. Biochemistry 47 12689-12697 (2008)
- Linking folding with aggregation in Alzheimer's beta-amyloid peptides. Khandogin J, Brooks CL. Proc Natl Acad Sci U S A 104 16880-16885 (2007)
- FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease. Kam TI, Song S, Gwon Y, Park H, Yan JJ, Im I, Choi JW, Choi TY, Kim J, Song DK, Takai T, Kim YC, Kim KS, Choi SY, Choi S, Klein WL, Yuan J, Jung YK. J Clin Invest 123 2791-2802 (2013)
- Positioning of the Alzheimer Abeta(1-40) peptide in SDS micelles using NMR and paramagnetic probes. Jarvet J, Danielsson J, Damberg P, Oleszczuk M, Gräslund A. J Biomol NMR 39 63-72 (2007)
- Crucial role of nonspecific interactions in amyloid nucleation. Šarić A, Chebaro YC, Knowles TP, Frenkel D. Proc Natl Acad Sci U S A 111 17869-17874 (2014)
- Solvent and mutation effects on the nucleation of amyloid beta-protein folding. Cruz L, Urbanc B, Borreguero JM, Lazo ND, Teplow DB, Stanley HE. Proc Natl Acad Sci U S A 102 18258-18263 (2005)
- Effect of surfaces on amyloid fibril formation. Moores B, Drolle E, Attwood SJ, Simons J, Leonenko Z. PLoS One 6 e25954 (2011)
- Protofibril formation of amyloid beta-protein at low pH via a non-cooperative elongation mechanism. Carrotta R, Manno M, Bulone D, Martorana V, San Biagio PL. J Biol Chem 280 30001-30008 (2005)
- The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motif. Maloney B, Lahiri DK. Gene 488 1-12 (2011)
- Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer. Lin YS, Bowman GR, Beauchamp KA, Pande VS. Biophys J 102 315-324 (2012)
- Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-beta peptide. Chi EY, Ege C, Winans A, Majewski J, Wu G, Kjaer K, Lee KY. Proteins 72 1-24 (2008)
- 15N relaxation study of the amyloid beta-peptide: structural propensities and persistence length. Danielsson J, Andersson A, Jarvet J, Gräslund A. Magn Reson Chem 44 Spec No S114-21 (2006)
- Ion mobility separation coupled with MS detects two structural states of Alzheimer's disease Aβ1-40 peptide oligomers. Kłoniecki M, Jabłonowska A, Poznański J, Langridge J, Hughes C, Campuzano I, Giles K, Dadlez M. J Mol Biol 407 110-124 (2011)
- Abeta oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures. Picone P, Carrotta R, Montana G, Nobile MR, San Biagio PL, Di Carlo M. Biophys J 96 4200-4211 (2009)
- Determining the critical nucleus and mechanism of fibril elongation of the Alzheimer's Abeta(1-40) peptide. Fawzi NL, Okabe Y, Yap EH, Head-Gordon T. J Mol Biol 365 535-550 (2007)
- Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions. Olofsson A, Lindhagen-Persson M, Sauer-Eriksson AE, Ohman A. Biochem J 404 63-70 (2007)
- Distinct thermodynamic signatures of oligomer generation in the aggregation of the amyloid-β peptide. Cohen SIA, Cukalevski R, Michaels TCT, Šarić A, Törnquist M, Vendruscolo M, Dobson CM, Buell AK, Knowles TPJ, Linse S. Nat Chem 10 523-531 (2018)
- Dimer formation enhances structural differences between amyloid β-protein (1-40) and (1-42): an explicit-solvent molecular dynamics study. Barz B, Urbanc B. PLoS One 7 e34345 (2012)
- Molecular insight into conformational transition of amyloid β-peptide 42 inhibited by (-)-epigallocatechin-3-gallate probed by molecular simulations. Liu FF, Dong XY, He L, Middelberg AP, Sun Y. J Phys Chem B 115 11879-11887 (2011)
- Mechanism of fiber assembly: treatment of Aβ peptide aggregation with a coarse-grained united-residue force field. Rojas A, Liwo A, Browne D, Scheraga HA. J Mol Biol 404 537-552 (2010)
- Structures of beta-amyloid peptide 1-40, 1-42, and 1-55-the 672-726 fragment of APP-in a membrane environment with implications for interactions with gamma-secretase. Miyashita N, Straub JE, Thirumalai D. J Am Chem Soc 131 17843-17852 (2009)
- NMR structure in a membrane environment reveals putative amyloidogenic regions of the SEVI precursor peptide PAP(248-286). Nanga RP, Brender JR, Vivekanandan S, Popovych N, Ramamoorthy A. J Am Chem Soc 131 17972-17979 (2009)
- Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer's disease. Duan S, Guan X, Lin R, Liu X, Yan Y, Lin R, Zhang T, Chen X, Huang J, Sun X, Li Q, Fang S, Xu J, Yao Z, Gu H. Neurobiol Aging 36 1792-1807 (2015)
- Amyloidogenic sequences in native protein structures. Tzotzos S, Doig AJ. Protein Sci 19 327-348 (2010)
- Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water. Lee C, Ham S. J Comput Chem 32 349-355 (2011)
- Amyloid β peptides aggregation in a mixed membrane bilayer: a molecular dynamics study. Zhao LN, Chiu SW, Benoit J, Chew LY, Mu Y. J Phys Chem B 115 12247-12256 (2011)
- Structures and free-energy landscapes of the wild type and mutants of the Abeta(21-30) peptide are determined by an interplay between intrapeptide electrostatic and hydrophobic interactions. Tarus B, Straub JE, Thirumalai D. J Mol Biol 379 815-829 (2008)
- Models of membrane-bound Alzheimer's Abeta peptide assemblies. Shafrir Y, Durell S, Arispe N, Guy HR. Proteins 78 3473-3487 (2010)
- Comparing the Aggregation Free Energy Landscapes of Amyloid Beta(1-42) and Amyloid Beta(1-40). Zheng W, Tsai MY, Wolynes PG. J Am Chem Soc 139 16666-16676 (2017)
- Interplay of histidine residues of the Alzheimer's disease Aβ peptide governs its Zn-induced oligomerization. Istrate AN, Kozin SA, Zhokhov SS, Mantsyzov AB, Kechko OI, Pastore A, Makarov AA, Polshakov VI. Sci Rep 6 21734 (2016)
- Toxicity of recombinant beta-amyloid prefibrillar oligomers on the morphogenesis of the sea urchin Paracentrotus lividus. Carrotta R, Di Carlo M, Manno M, Montana G, Picone P, Romancino D, San Biagio PL. FASEB J 20 1916-1917 (2006)
- Adsorption mechanism and collapse propensities of the full-length, monomeric Aβ(1-42) on the surface of a single-walled carbon nanotube: a molecular dynamics simulation study. Jana AK, Sengupta N. Biophys J 102 1889-1896 (2012)
- Structure of amyloid beta fragments in aqueous environments. Takano K, Endo S, Mukaiyama A, Chon H, Matsumura H, Koga Y, Kanaya S. FEBS J 273 150-158 (2006)
- The Dependence of Amyloid-β Dynamics on Protein Force Fields and Water Models. Somavarapu AK, Kepp KP. Chemphyschem 16 3278-3289 (2015)
- Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data. Kocis P, Tolar M, Yu J, Sinko W, Ray S, Blennow K, Fillit H, Hey JA. CNS Drugs 31 495-509 (2017)
- Solution NMR studies of recombinant Aβ(1-42): from the presence of a micellar entity to residual β-sheet structure in the soluble species. Wälti MA, Orts J, Vögeli B, Campioni S, Riek R. Chembiochem 16 659-669 (2015)
- Structural requirements for antimicrobial versus chemoattractant activities for dermaseptin S9. Auvynet C, El Amri C, Lacombe C, Bruston F, Bourdais J, Nicolas P, Rosenstein Y. FEBS J 275 4134-4151 (2008)
- Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, Aβ1-42 aggregation inhibitors and metal-chelating agents for Alzheimer's disease. Xu P, Zhang M, Sheng R, Ma Y. Eur J Med Chem 127 174-186 (2017)
- Structure and topology of the non-amyloid-beta component fragment of human alpha-synuclein bound to micelles: implications for the aggregation process. Bisaglia M, Trolio A, Bellanda M, Bergantino E, Bubacco L, Mammi S. Protein Sci 15 1408-1416 (2006)
- Autoinsertion of soluble oligomers of Alzheimer's Abeta(1-42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface. Ashley RH, Harroun TA, Hauss T, Breen KC, Bradshaw JP. BMC Struct Biol 6 21 (2006)
- Inhibition of amyloid beta-induced synaptotoxicity by a pentapeptide derived from the glycine zipper region of the neurotoxic peptide. Peters C, Fernandez-Perez EJ, Burgos CF, Espinoza MP, Castillo C, Urrutia JC, Streltsov VA, Opazo C, Aguayo LG. Neurobiol Aging 34 2805-2814 (2013)
- Misfolding of the amyloid beta-protein: a molecular dynamics study. Flöck D, Colacino S, Colombo G, Di Nola A. Proteins 62 183-192 (2006)
- The effect of Abeta conformation on the metal affinity and aggregation mechanism studied by circular dichroism spectroscopy. Chen YR, Huang HB, Chyan CL, Shiao MS, Lin TH, Chen YC. J Biochem 139 733-740 (2006)
- Letter Effects of familial mutations on the monomer structure of Aβ₄₂. Lin YS, Pande VS. Biophys J 103 L47-9 (2012)
- A study of the α-helical intermediate preceding the aggregation of the amino-terminal fragment of the β amyloid peptide (Aβ(1-28)). Rojas AV, Liwo A, Scheraga HA. J Phys Chem B 115 12978-12983 (2011)
- The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency. Brender JR, Nanga RP, Popovych N, Soong R, Macdonald PM, Ramamoorthy A. Biochim Biophys Acta 1808 1161-1169 (2011)
- The protective effect of crocin on the amyloid fibril formation of Aβ42 peptide in vitro. Ghahghaei A, Bathaie SZ, Kheirkhah H, Bahraminejad E. Cell Mol Biol Lett 18 328-339 (2013)
- Thermodynamically stable amyloid-β monomers have much lower membrane affinity than the small oligomers. Sarkar B, Das AK, Maiti S. Front Physiol 4 84 (2013)
- Effects of amyloid beta-peptides on the lysis tension of lipid bilayer vesicles containing oxysterols. Kim DH, Frangos JA. Biophys J 95 620-628 (2008)
- Antioxidant Berberine-Derivative Inhibits Multifaceted Amyloid Toxicity. Rajasekhar K, Samanta S, Bagoband V, Murugan NA, Govindaraju T. iScience 23 101005 (2020)
- Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils. Shafrir Y, Durell SR, Anishkin A, Guy HR. Proteins 78 3458-3472 (2010)
- Glycation affects fibril formation of Aβ peptides. Emendato A, Milordini G, Zacco E, Sicorello A, Dal Piaz F, Guerrini R, Thorogate R, Picone D, Pastore A. J Biol Chem 293 13100-13111 (2018)
- Processing amyloid precursor protein at the beta-site requires proper orientation to be accessed by BACE1. Qahwash I, He W, Tomasselli A, Kletzien RF, Yan R. J Biol Chem 279 39010-39016 (2004)
- Turn nucleation perturbs amyloid β self-assembly and cytotoxicity. Doran TM, Anderson EA, Latchney SE, Opanashuk LA, Nilsson BL. J Mol Biol 421 315-328 (2012)
- Alzheimer's Abeta40 studied by NMR at low pH reveals that sodium 4,4-dimethyl-4-silapentane-1-sulfonate (DSS) binds and promotes beta-ball oligomerization. Laurents DV, Gorman PM, Guo M, Rico M, Chakrabartty A, Bruix M. J Biol Chem 280 3675-3685 (2005)
- Amyloid peptide Aβ40 inhibits aggregation of Aβ42: evidence from molecular dynamics simulations. Viet MH, Li MS. J Chem Phys 136 245105 (2012)
- Exploration of the mechanism for LPFFD inhibiting the formation of beta-sheet conformation of A beta(1-42) in water. Yang C, Zhu X, Li J, Shi R. J Mol Model 16 813-821 (2010)
- Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides. Chong SH, Yim J, Ham S. Mol Biosyst 9 997-1003 (2013)
- Distinct conformational states of the Alzheimer β-amyloid peptide can be detected by high-pressure NMR spectroscopy. Munte CE, Beck Erlach M, Kremer W, Koehler J, Kalbitzer HR. Angew Chem Int Ed Engl 52 8943-8947 (2013)
- Unfolding of the amyloid β-peptide central helix: mechanistic insights from molecular dynamics simulations. Ito M, Johansson J, Strömberg R, Nilsson L. PLoS One 6 e17587 (2011)
- 3D NMR structure of a complex between the amyloid beta peptide (1-40) and the polyphenol ε-viniferin glucoside: implications in Alzheimer's disease. Richard T, Papastamoulis Y, Waffo-Teguo P, Monti JP. Biochim Biophys Acta 1830 5068-5074 (2013)
- A synchrotron-based hydroxyl radical footprinting analysis of amyloid fibrils and prefibrillar intermediates with residue-specific resolution. Klinger AL, Kiselar J, Ilchenko S, Komatsu H, Chance MR, Axelsen PH. Biochemistry 53 7724-7734 (2014)
- Alzheimer's disease amyloid beta peptides in vitro electrochemical oxidation. Enache TA, Oliveira-Brett AM. Bioelectrochemistry 114 13-23 (2017)
- Atomic decomposition of the protein solvation free energy and its application to amyloid-beta protein in water. Chong SH, Ham S. J Chem Phys 135 034506 (2011)
- Investigating the Neuroprotective Effects of Turmeric Extract: Structural Interactions of β-Amyloid Peptide with Single Curcuminoids. Randino R, Grimaldi M, Persico M, De Santis A, Cini E, Cabri W, Riva A, D'Errico G, Fattorusso C, D'Ursi AM, Rodriquez M. Sci Rep 6 38846 (2016)
- Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching. Bukhbinder AS, Ling Y, Hasan O, Jiang X, Kim Y, Phelps KN, Schmandt RE, Amran A, Coburn R, Ramesh S, Xiao Q, Schulz PE. J Alzheimers Dis 88 1061-1074 (2022)
- Structures of the glycine-rich diastereomeric peptides bombinin H2 and H4. Zangger K, Gössler R, Khatai L, Lohner K, Jilek A. Toxicon 52 246-254 (2008)
- Induced Dipole-Dipole Interactions Influence the Unfolding Pathways of Wild-Type and Mutant Amyloid β-Peptides. Lemkul JA, Huang J, MacKerell AD. J Phys Chem B 119 15574-15582 (2015)
- Mitochondrial accumulation of amyloid β (Aβ) peptides requires TOMM22 as a main Aβ receptor in yeast. Hu W, Wang Z, Zheng H. J Biol Chem 293 12681-12689 (2018)
- Physico-chemical features of the environment affect the protein conformation and the immunoglobulin E reactivity of kiwellin (Act d 5). Bernardi ML, Picone D, Tuppo L, Giangrieco I, Petrella G, Palazzo P, Ferrara R, Tamburrini M, Mari A, Ciardiello MA. Clin Exp Allergy 40 1819-1826 (2010)
- Structural analysis of the pyroglutamate-modified isoform of the Alzheimer's disease-related amyloid-β using NMR spectroscopy. Sun N, Hartmann R, Lecher J, Stoldt M, Funke SA, Gremer L, Ludwig HH, Demuth HU, Kleinschmidt M, Willbold D. J Pept Sci 18 691-695 (2012)
- The Alzheimer's beta amyloid (Abeta1-39) monomer in an implicit solvent. Anand P, Nandel FS, Hansmann UH. J Chem Phys 128 165102 (2008)
- Amyloid beta(1-42) in aqueous environments: effects of ionic strength and E22Q (Dutch) mutation. Bossis F, Palese LL. Biochim Biophys Acta 1834 2486-2493 (2013)
- An azobenzene photoswitch sheds light on turn nucleation in amyloid-β self-assembly. Doran TM, Anderson EA, Latchney SE, Opanashuk LA, Nilsson BL. ACS Chem Neurosci 3 211-220 (2012)
- Glycation of Lys-16 and Arg-5 in amyloid-β and the presence of Cu2+ play a major role in the oxidative stress mechanism of Alzheimer's disease. Fica-Contreras SM, Shuster SO, Durfee ND, Bowe GJK, Henning NJ, Hill SA, Vrla GD, Stillman DR, Suralik KM, Sandwick RK, Choi S. J Biol Inorg Chem 22 1211-1222 (2017)
- Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway. Di Carlo MG, Minicozzi V, Foderà V, Militello V, Vetri V, Morante S, Leone M. Biophys Chem 206 1-11 (2015)
- Computational study of the binding of CuII to Alzheimer's amyloid-beta peptide: do Abeta42 and Abeta40 bind copper in identical fashion? Mantri Y, Fioroni M, Baik MH. J Biol Inorg Chem 13 1197-1204 (2008)
- Electrically induced conformational change of peptides on metallic nanosurfaces. Chen Y, Cruz-Chu ER, Woodard JC, Gartia MR, Schulten K, Liu L. ACS Nano 6 8847-8856 (2012)
- Intrinsic thermal expansivity and hydrational properties of amyloid peptide Abeta42 in liquid water. Brovchenko I, Burri RR, Krukau A, Oleinikova A, Winter R. J Chem Phys 129 195101 (2008)
- Structural Analysis and Aggregation Propensity of Pyroglutamate Aβ(3-40) in Aqueous Trifluoroethanol. Dammers C, Gremer L, Reiß K, Klein AN, Neudecker P, Hartmann R, Sun N, Demuth HU, Schwarten M, Willbold D. PLoS One 10 e0143647 (2015)
- Structural analysis of membrane-bound hECE-1 dimer using molecular modeling techniques: insights into conformational changes and Aβ1-42 peptide binding. Sonawane KD, Barage SH. Amino Acids 47 543-559 (2015)
- Aggregation of Aß(25-35) on DOPC and DOPC/DHA bilayers: an atomic force microscopy study. Sublimi Saponetti M, Grimaldi M, Scrima M, Albonetti C, Nori SL, Cucolo A, Bobba F, D'Ursi AM. PLoS One 9 e115780 (2014)
- Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action. Sharma S, Nehru B, Saini A. Neurochem Int 108 481-493 (2017)
- Pretreatment of chemically-synthesized Aβ42 affects its biological activity in yeast. Porzoor A, Caine JM, Macreadie IG. Prion 8 404-410 (2014)
- Structural and functional properties of peptides based on the N-terminus of HIV-1 gp41 and the C-terminus of the amyloid-beta protein. Gordon LM, Nisthal A, Lee AB, Eskandari S, Ruchala P, Jung CL, Waring AJ, Mobley PW. Biochim Biophys Acta 1778 2127-2137 (2008)
- Elucidating the Molecular Determinants of Aβ Aggregation with Deep Mutational Scanning. Gray VE, Sitko K, Kameni FZN, Williamson M, Stephany JJ, Hasle N, Fowler DM. G3 (Bethesda) 9 3683-3689 (2019)
- FTIR spectroscopic studies on aggregation process of the beta-amyloid 11-28 fragment and its variants. Juszczyk P, Kołodziejczyk AS, Grzonka Z. J Pept Sci 15 23-29 (2009)
- Fibrillation-prone conformations of the amyloid-β-42 peptide at the gold/water interface. Bellucci L, Bussi G, Di Felice R, Corni S. Nanoscale 9 2279-2290 (2017)
- Heme prevents amyloid beta peptide aggregation through hydrophobic interaction based on molecular dynamics simulation. Zhao LN, Mu Y, Chew LY. Phys Chem Chem Phys 15 14098-14106 (2013)
- Influence of sequence and lipid type on membrane perturbation by human and rat amyloid β-peptide (1-42). Brown AM, Bevan DR. Arch Biochem Biophys 614 1-13 (2017)
- Insights into the Interaction Mechanism of Ligands with Aβ42 Based on Molecular Dynamics Simulations and Mechanics: Implications of Role of Common Binding Site in Drug Design for Alzheimer's Disease. Kundaikar HS, Degani MS. Chem Biol Drug Des 86 805-812 (2015)
- Model of Alzheimer's disease amyloid-beta peptide based on a RNA binding protein. Mathura VS, Paris D, Ait-Ghezala G, Quadros A, Patel NS, Kolippakkam DN, Volmar CH, Mullan MJ. Biochem Biophys Res Commun 332 585-592 (2005)
- Surfactant protein C peptides with salt-bridges ("ion-locks") promote high surfactant activities by mimicking the α-helix and membrane topography of the native protein. Walther FJ, Waring AJ, Hernández-Juviel JM, Ruchala P, Wang Z, Notter RH, Gordon LM. PeerJ 2 e485 (2014)
- Synthesis and characterization of 1H-phenanthro[9,10-d]imidazole derivatives as multifunctional agents for treatment of Alzheimer's disease. Liu J, Qiu J, Wang M, Wang L, Su L, Gao J, Gu Q, Xu J, Huang SL, Gu LQ, Huang ZS, Li D. Biochim Biophys Acta 1840 2886-2903 (2014)
- Alzheimer's peptide amyloid-β, fragment 22-40, perturbs lipid dynamics. Barrett MA, Trapp M, Lohstroh W, Seydel T, Ollivier J, Ballauff M, Dencher NA, Hauß T. Soft Matter 12 1444-1451 (2016)
- Effect of Amyloid-β Monomers on Lipid Membrane Mechanical Parameters-Potential Implications for Mechanically Driven Neurodegeneration in Alzheimer's Disease. Drabik D, Chodaczek G, Kraszewski S. Int J Mol Sci 22 E18 (2020)
- Insights into the molecular interactions between aminopeptidase and amyloid beta peptide using molecular modeling techniques. Dhanavade MJ, Sonawane KD. Amino Acids 46 1853-1866 (2014)
- Modeling the binding mechanism of Alzheimer's Aβ1-42 to nicotinic acetylcholine receptors based on similarity with snake α-neurotoxins. Maatuk N, Samson AO. Neurotoxicology 34 236-242 (2013)
- Nuclear magnetic resonance evidence for the dimer formation of beta amyloid peptide 1-42 in 1,1,1,3,3,3-hexafluoro-2-propanol. Shigemitsu Y, Iwaya N, Goda N, Matsuzaki M, Tenno T, Narita A, Hoshi M, Hiroaki H. Anal Biochem 498 59-67 (2016)
- The sea urchin embryo: a model to study Alzheimer's beta amyloid induced toxicity. Pellicanò M, Picone P, Cavalieri V, Carrotta R, Spinelli G, Di Carlo M. Arch Biochem Biophys 483 120-126 (2009)
- pH changes the aggregation propensity of amyloid-β without altering the monomer conformation. Bhowmik D, MacLaughlin CM, Chandrakesan M, Ramesh P, Venkatramani R, Walker GC, Maiti S. Phys Chem Chem Phys 16 885-889 (2014)
- Characterization of Aβ aggregation mechanism probed by congo red. Wang CC, Huang HB, Tsay HJ, Shiao MS, Wu WJ, Cheng YC, Lin TH. J Biomol Struct Dyn 30 160-169 (2012)
- Preliminary studies on trigonelline as potential anti-Alzheimer disease agent: determination by hydrophilic interaction liquid chromatography and modeling of interactions with beta-amyloid. Makowska J, Szczesny D, Lichucka A, Giełdoń A, Chmurzyński L, Kaliszan R. J Chromatogr B Analyt Technol Biomed Life Sci 968 101-104 (2014)
- Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β42 monomer: insights from molecular dynamics simulations. Shuaib S, Goyal B. J Biomol Struct Dyn 36 663-678 (2018)
- Structural study of caveolin-1 intramembrane domain by circular dichroism and nuclear magnetic resonance. Yang G, Dong Z, Xu H, Wang C, Li H, Li Z, Li F. Biopolymers 104 11-20 (2015)
- Translational, rotational and internal dynamics of amyloid beta-peptides (Abeta40 and Abeta42) from molecular dynamics simulations. Bora RP, Prabhakar R. J Chem Phys 131 155103 (2009)
- pH effects on the conformational preferences of amyloid beta-peptide (1-40) in HFIP aqueous solution by NMR spectroscopy. Valerio M, Porcelli F, Zbilut JP, Giuliani A, Manetti C, Conti F. ChemMedChem 3 833-843 (2008)
- Detection of Amyloid Beta (Aβ) Oligomeric Composition Using Matrix-Assisted Laser Desorption Ionization Mass Spectrometry (MALDI MS). Wang JS, Whitehead SN, Yeung KK. J Am Soc Mass Spectrom 29 786-795 (2018)
- Is the Conformational Ensemble of Alzheimer's Aβ10-40 Peptide Force Field Dependent? Siwy CM, Lockhart C, Klimov DK. PLoS Comput Biol 13 e1005314 (2017)
- Systematic Review Microbial Pathogenesis and Pathophysiology of Alzheimer's Disease: A Systematic Assessment of Microorganisms' Implications in the Neurodegenerative Disease. Ekundayo TC, Olasehinde TA, Okaiyeto K, Okoh AI. Front Neurosci 15 648484 (2021)
- Pathogenic properties of Alzheimer's β-amyloid identified from structure-property patient-phenotype correlations. Tiwari MK, Kepp KP. Dalton Trans 44 2747-2754 (2015)
- Pyroglutamate-Modified Amyloid-β(3-42) Shows α-Helical Intermediates before Amyloid Formation. Dammers C, Reiss K, Gremer L, Lecher J, Ziehm T, Stoldt M, Schwarten M, Willbold D. Biophys J 112 1621-1633 (2017)
- Site-directed analysis on protein hydrophobicity. Chong SH, Ham S. J Comput Chem 35 1364-1370 (2014)
- A routine method for cloning, expressing and purifying Aβ(1-42) for structural NMR studies. Weber DK, Sani MA, Gehman JD. Amino Acids 46 2415-2426 (2014)
- A sequence-based method for predicting extant fold switchers that undergo α-helix ↔ β-strand transitions. Mishra S, Looger LL, Porter LL. Biopolymers 112 e23471 (2021)
- Conformational features of the Aβ42 peptide monomer and its interaction with the surrounding solvent. Khatua P, Jose JC, Sengupta N, Bandyopadhyay S. Phys Chem Chem Phys 18 30144-30159 (2016)
- Does aluminium bind to histidine? An NMR investigation of amyloid β12 and amyloid β16 fragments. Narayan P, Krishnarjuna B, Vishwanathan V, Jagadeesh Kumar D, Babu S, Ramanathan KV, Easwaran KR, Nagendra HG, Raghothama S. Chem Biol Drug Des 82 48-59 (2013)
- In vitro reconstitution of a cell-like environment using liposomes for amyloid beta peptide aggregation and its propagation. Saha A, Mondal G, Biswas A, Chakraborty I, Jana B, Ghosh S. Chem Commun (Camb) 49 6119-6121 (2013)
- Probing Medin Monomer Structure and its Amyloid Nucleation Using 13C-Direct Detection NMR in Combination with Structural Bioinformatics. Davies HA, Rigden DJ, Phelan MM, Madine J. Sci Rep 7 45224 (2017)
- Crowding versus molecular seeding: NMR studies of protein aggregation in hen egg white. Sanfelice D, Adrover M, Martorell G, Pastore A, Temussi PA. J Phys Condens Matter 24 244107 (2012)
- Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans. Emendato A, Guerrini R, Marzola E, Wienk H, Boelens R, Leone S, Picone D. Front Mol Biosci 5 100 (2018)
- Fibril aggregation inhibitory activity of the beta-sheet breaker peptides: a molecular docking approach. Chini MG, Scrima M, D'Ursi AM, Bifulco G. J Pept Sci 15 229-234 (2009)
- Peptide-induced membrane curvature in edge-stabilized open bilayers: a theoretical and molecular dynamics study. Pannuzzo M, Raudino A, Böckmann RA. J Chem Phys 141 024901 (2014)
- Sequence-based modeling of Abeta42 soluble oligomers. Dulin F, Callebaut I, Colloc'h N, Mornon JP. Biopolymers 85 422-437 (2007)
- Study on structure and assembly of the third transmembrane domain of Slc11a1. Xiao S, Wang Y, Yang L, Qi H, Wang C, Li F. J Pept Sci 16 249-255 (2010)
- Tracking the mechanism of fibril assembly by simulated two-dimensional ultraviolet spectroscopy. Lam AR, Rodriguez JJ, Rojas A, Scheraga HA, Mukamel S. J Phys Chem A 117 342-350 (2013)
- Alignment of Alzheimer's Disease Amyloid-β Peptide and Herpes Simplex Virus-1 pUL15 C-Terminal Nuclease Domain. Lehrer S, Rheinstein PH. J Alzheimers Dis Rep 4 373-377 (2020)
- Computational Investigation of Gantenerumab and Crenezumab Recognition of Aβ Fibrils in Alzheimer's Disease Brain Tissue. Chen Y, Wei G, Zhao J, Nussinov R, Ma B. ACS Chem Neurosci 11 3233-3244 (2020)
- Computational approach for the assessment of inhibitory potency against beta-amyloid aggregation. Bajda M, Filipek S. Bioorg Med Chem Lett 27 212-216 (2017)
- Conformational solution studies of the SDS micelle-bound 11-28 fragment of two Alzheimer's beta-amyloid variants (E22K and A21G) using CD, NMR, and MD techniques. Rodziewicz-Motowidło S, Juszczyk P, Kołodziejczyk AS, Sikorska E, Skwierawska A, Oleszczuk M, Grzonka Z. Biopolymers 87 23-39 (2007)
- Fluorescence correlation spectroscopy reveals a cooperative unfolding of monomeric amyloid-β 42 with a low Gibbs free energy. Schneider M, Walta S, Cadek C, Richtering W, Willbold D. Sci Rep 7 2154 (2017)
- Identification of dibenzyl imidazolidine and triazole acetamide derivatives through virtual screening targeting amyloid beta aggregation and neurotoxicity in PC12 cells. Das S, Smid SD. Eur J Med Chem 130 354-364 (2017)
- Microsecond molecular dynamics simulation of Aβ42 and identification of a novel dual inhibitor of Aβ42 aggregation and BACE1 activity. Wang YY, Li L, Chen TT, Chen WY, Xu YC. Acta Pharmacol Sin 34 1243-1250 (2013)
- Novel β-amyloid aggregation inhibitors possessing a turn mimic. Hamada Y, Miyamoto N, Kiso Y. Bioorg Med Chem Lett 25 1572-1576 (2015)
- Preferential interaction of the Alzheimer peptide Aβ-(1-42) with Omega-3-containing lipid bilayers: structure and interaction studies. Emendato A, Spadaccini R, De Santis A, Guerrini R, D'Errico G, Picone D. FEBS Lett 590 582-591 (2016)
- Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure. Altman R, Ly S, Hilt S, Petrlova J, Maezawa I, Kálai T, Hideg K, Jin LW, Laurence TA, Voss JC. Biochim Biophys Acta 1854 1860-1870 (2015)
- Racemization in Post-Translational Modifications Relevance to Protein Aging, Aggregation and Neurodegeneration: Tip of the Iceberg. Dyakin VV, Wisniewski TM, Lajtha A. Symmetry (Basel) 13 455 (2021)
- Resolving the paradox for protein aggregation diseases: NMR structure and dynamics of the membrane-embedded P56S-MSP causing ALS imply a common mechanism for aggregation-prone proteins to attack membranes. Qin H, Lim L, Wei Y, Gupta G, Song J. F1000Res 2 221 (2013)
- Searching for an endogenous anti-Alzheimer molecule: identifying small molecules in the brain that slow Alzheimer disease progression by inhibition of ß-amyloid aggregation. Meek AR, Simms GA, Weaver DF. J Psychiatry Neurosci 38 269-275 (2013)
- Surface induced collapse of Aβ1-42 with the F19A replacement following adsorption on a single walled carbon nanotube. Jana AK, Sengupta N. Biophys Chem 184 108-115 (2013)
- Targeted studies on the interaction of nicotine and morin molecules with amyloid β-protein. Boopathi S, Kolandaivel P. J Mol Model 20 2109 (2014)
- The Role of Glycation on the Aggregation Properties of IAPP. Milordini G, Zacco E, Percival M, Puglisi R, Dal Piaz F, Temussi P, Pastore A. Front Mol Biosci 7 104 (2020)
- A Novel PEGylated Block Copolymer in New Age Therapeutics for Alzheimer's Disease. Som Chaudhury S, Sannigrahi A, Nandi M, Mishra VK, De P, Chattopadhyay K, Mishra S, Sil J, Das Mukhopadhyay C. Mol Neurobiol 56 6551-6565 (2019)
- Cell size effects in the molecular dynamics of the intrinsically disordered Aβ peptide. Mehra R, Kepp KP. J Chem Phys 151 085101 (2019)
- Design, synthesis and evaluation of 2-arylethenyl-N-methylquinolinium derivatives as effective multifunctional agents for Alzheimer's disease treatment. Xia CL, Wang N, Guo QL, Liu ZQ, Wu JQ, Huang SL, Ou TM, Tan JH, Wang HG, Li D, Huang ZS. Eur J Med Chem 130 139-153 (2017)
- Distinguishing amyloid fibril structures in Alzheimer's disease (AD) by two-dimensional ultraviolet (2DUV) spectroscopy. Lam AR, Jiang J, Mukamel S. Biochemistry 50 9809-9816 (2011)
- Positive evolutionary selection of an HD motif on Alzheimer precursor protein orthologues suggests a functional role. Miklós I, Zádori Z. PLoS Comput Biol 8 e1002356 (2012)
- Probing beta amyloid aggregation using fluorescence anisotropy: experiments and simulation. Mancini O, Wellbrock T, Rolinski OJ, Kubiak-Ossowska K, Mulheran PA. Phys Chem Chem Phys 20 4216-4225 (2018)
- Study of early stages of amyloid Aβ13-23 formation using molecular dynamics simulation in implicit environments. Bajda M, Filipek S. Comput Biol Chem 56 13-18 (2015)
- The Impact of Ag Nanoparticles and CdTe Quantum Dots on Expression and Function of Receptors Involved in Amyloid-β Uptake by BV-2 Microglial Cells. Sikorska K, Grądzka I, Wasyk I, Brzóska K, Stępkowski TM, Czerwińska M, Kruszewski MK. Materials (Basel) 13 E3227 (2020)
- Autocatalytic activation of influenza hemagglutinin. Lee JH, Goulian M, Boder ET. J Mol Biol 364 275-282 (2006)
- Calcium inhibits penetration of Alzheimer's Aβ1 -42 monomers into the membrane. Boopathi S, Garduño-Juárez R. Proteins 90 2124-2143 (2022)
- Dynamic observations of various oligomers in amyloid β isoforms using laboratory diffracted X-ray blinking. Chang J, Arai T, Kuramochi M, Inamasu R, Lee Z, Ohkubo T, Mio K, Sasaki YC. Biochem Biophys Rep 31 101298 (2022)
- Fullerenemalonates inhibit amyloid beta aggregation, in vitro and in silico evaluation. Melchor MH, Susana FG, Francisco GS, Hiram I B, Norma RF, Jorge A LR, Perla Y LC, Gustavo BI. RSC Adv 8 39667-39677 (2018)
- Molecular Simulations of Human and Mouse Aβ1-16 at Different pH Values: Structural Characteristics toward Understanding Cu(2+) -Coordinated Amyloid Beta Spheres. Zhang R, Ai H, Zhu X, Li Q. Chemphyschem 17 1656-1668 (2016)
- Neuroprotective activity of selenium nanoparticles against the effect of amino acid enantiomers in Alzheimer's disease. Vicente-Zurdo D, Rodríguez-Blázquez S, Gómez-Mejía E, Rosales-Conrado N, León-González ME, Madrid Y. Anal Bioanal Chem 414 7573-7584 (2022)
- The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ1-42 fibrils in Alzheimer's disease: insight from in-vitro and in-silico studies. Hojati S, Ghahghaei A, Lagzian M. J Biomol Struct Dyn 36 2118-2130 (2018)
- Aggregation-Prone Structural Ensembles of Transthyretin Collected With Regression Analysis for NMR Chemical Shift. Yang W, Kim BS, Muniyappan S, Lee YH, Kim JH, Yu W. Front Mol Biosci 8 766830 (2021)
- Alignment of Alzheimer's disease amyloid β-peptide and klotho. Lehrer S, Rheinstein PH. World Acad Sci J 2 27 (2020)
- An interchangeable prion-like domain is required for Ty1 retrotransposition. Beckwith SL, Nomberg EJ, Newman AC, Taylor JV, Guerrero-Ferreira RC, Garfinkel DJ. Proc Natl Acad Sci U S A 120 e2303358120 (2023)
- Dual Effects of Presynaptic Membrane Mimetics on α-Synuclein Amyloid Aggregation. Lin Y, Ito D, Yoo JM, Lim MH, Yu W, Kawata Y, Lee YH. Front Cell Dev Biol 10 707417 (2022)
- Editorial In silico-designed novel non-peptidic ABAD LD hot spot mimetics reverse Aβ-induced mitochondrial impairments in vitro. Viswanath ANI, Kim T, Jung SY, Lim SM, Pae AN. Chem Biol Drug Des 90 1041-1055 (2017)
- Initial Structural Models of the Aβ42 Dimer from Replica Exchange Molecular Dynamics Simulations. Blinov N, Khorvash M, Wishart DS, Cashman NR, Kovalenko A. ACS Omega 2 7621-7636 (2017)
- Molecular interactions with redox sites and salt bridges modulate the anti-aggregatory effect of flavonoid, tannin and cardenolide moieties against amyloid-beta (1-42) in silico. Manalo RVM. In Silico Pharmacol 5 11 (2017)
- Spontaneous self-assembly of amyloid β (1-40) into dimers. Hashemi M, Zhang Y, Lv Z, Lyubchenko YL. Nanoscale Adv 1 3892-3899 (2019)
- (E)-Ethyl-2-cyano-2-(((2,4,6-trichlorobenzoyl)oxy)imino)acetate: A Modified Yamaguchi Reagent for Enantioselective Esterification, Thioesterification, Amidation, and Peptide Synthesis. Chandra J, Manne SR, Mondal S, Mandal B. ACS Omega 3 6120-6133 (2018)
- Historical Article 50 years of The FEBS Journal: looking back as well as ahead. Chenette EJ, Martin SJ. FEBS J 284 4162-4171 (2017)
- In Vitro Screening and MD Simulations of Thiourea Derivatives against SARS-CoV-2 in Association with Multidrug Resistance ABCB1 Transporter. Assad M, Parveen Z, Farman S, Khurshid B, Hashmi MA, Khan KM, Khurshid A. ACS Omega 7 47671-47679 (2022)
- Affected albumin endocytosis as a new neurotoxicity mechanism of amyloid beta. Rasgado LAV, Urbieta AT, Jiménez JMM. AIMS Neurosci 7 344-359 (2020)
- Characterization of Amyloidogenic Peptide Aggregability in Helical Subspace. Bhattacharya S, Xu L, Thompson D. Methods Mol Biol 2340 401-448 (2022)
- Deciphering neuroprotective mechanism of nitroxoline in cerebral ischemia: network pharmacology and molecular modeling-based investigations. Vadak N, Borkar MR, Bhatt LK. Mol Divers (2024)
- Do vaccinations influence the development of Alzheimer disease? Bukhbinder AS, Ling Y, Harris K, Jiang X, Schulz PE. Hum Vaccin Immunother 19 2216625 (2023)
- Does the electrical activity of neurons contribute to the pathogenesis of Alzheimer's Disease? Concepcion GP, Padlan EA. Med Hypotheses 74 27-28 (2010)
- Effect of mutation on Aβ1-42-Heme complex in aggregation mechanism: Alzheimer's disease. Boopathi S, Kolandaivel P. J Mol Graph Model 76 224-233 (2017)
- Epitope Mapping by NMR of a Novel Anti-Aβ Antibody (STAB-MAb). Posado-Fernández A, Afonso CF, Dória G, Flores O, Cabrita EJ. Sci Rep 9 12241 (2019)
- Expression, Purification, and Monitoring of Conformational Changes of hCB2 TMH67H8 in Different Membrane-Mimetic Lipid Mixtures Using Circular Dichroism and NMR Techniques. Tiburu EK, Zhuang J, Fleischer HN, Arthur PK, Awandare GA. Membranes (Basel) 7 E10 (2017)
- Monitoring the Conformational Changes of the Aβ(25-35) Peptide in SDS Micelles: A Matter of Time. Santoro A, Buonocore M, Grimaldi M, Napolitano E, D'Ursi AM. Int J Mol Sci 24 971 (2023)
- Self-assembly of a peptide with a tandem repeat of the Aβ16-22 sequence linked by a β turn-promoting dipeptide sequence. Sivakama Sundari C, Bikshapathy E, Nagaraj R. Biopolymers 104 790-803 (2015)
- Structural analysis of oligomeric and protofibrillar Aβ amyloid pair structures considering F20L mutation effects using molecular dynamics simulations. Lee M, Chang HJ, Baek I, Na S. Proteins 85 580-592 (2017)